LYT-100 in Patients With BCRL

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Breast Cancer Related Lymphoedema, Lymphoedema

In brief

This is a trial of up to 6-months duration for safety, tolerability, clinical efficacy assessments, PK and biomarkers analysis in breast carcinoma patients with secondary lymphoedema

Key facts

Study ID

NCT04243837

Run by

PureTech

People needed

50

Starts

2020-03-01

Expected to finish

2022-09-09

Last updated by the study team

2024-04-23

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

Where it is running

• City of Hope National Medical Center — Duarte, California, United States
• MACRO Trials — Los Angeles, California, United States
• Accel Research Network — Maitland, Florida, United States
• Accel Research Network — Atlanta, Georgia, United States
• University of the Sunshine Coast — Sippy Downs, Queensland, Australia
• Ballarat Health Services — Ballarat, Victoria, Australia
• Flinders University — Adelaide, Australia
• Macquarie University Health Sciences Centre — Sydney, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.